Entero Healthcar — 360° view

Entero Healthcar, a company in the Pharmacy Retail industry, reported revenue of ₹2,087 crore and net profit of ₹61 crore for the September 2026 quarter.

Entero Healthcar (NSE: ENTERO) closed at ₹1,901.80 on 20 Nov 2026, up 77.7% over the past year. Its market capitalisation is ₹8,285 crore and it trades at 57.9 times earnings.

Share price
₹1,901.80 (20 Nov 2026)
Market cap
₹8,285 Cr (20 Nov 2026)
P/E
57.94 (20 Nov 2026)
Revenue
₹2,087 Cr (September 2026 quarter)
Net profit
₹61 Cr (September 2026 quarter)
ROCE
10.5% (FY26)
ROE
6.94% (FY26)
Book value
₹409 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹2,137.60 / ₹944.00 (20 Nov 2026)
1-year return
77.7% (to 20 Nov 2026)
Sector
Consumer Discretionary
Industry
Pharmacy Retail
Symbol
NSE: ENTERO

Incorporated in 2018, Entero Healthcare Solutions Ltd is in the business of distribution and marketing of pharmaceutical and surgical products and allied services

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.